Centers for Medicare and Medicaid Services

The Centers for Medicare and Medicaid Services (CMS) are now formalizing rapid coverage decisions, and higher launch prices, for mRNA vaccines.

FDA’s move brings it into closer alignment with CMS and big commercial payers.

The Centers for Medicare and Medicaid Services (CMS) is starting pilot 'cell and gene therapy access models,' amplifying these commercial experiments.

This revolving door isn’t new.